Abstract Target-specific next-generation sequencing technology was used to analyze 112 genes in adult patients with acute lymphoblastic leukemia (ALL). This sequencing mainly focused on the specific mutational hotspots. Among the 121 patients, 93 patients were B-ALL (76.9%), and 28 patients (23.1%) were T-ALL. Of the 121 patients, 110 (90.9%) harbored at least one mutation. The five most frequently mutated genes in T-ALL are NOTCH1, JAK3, FBXW7, FAT1, and NRAS. In B-ALL, FAT1, SF1, CRLF2, TET2, and PTPN1 have higher incidence of mutations. Gene mutations are different between Ph+ALL and Ph−ALL patients. B-ALL patients with PTPN11 mutation and T-ALL patients with NOTCH1 and/or FBXW7 mutations showed better survival. But B-ALL with JAK1/JAK2 ...
International audiencePURPOSE: The Group for Research in Adult Acute Lymphoblastic Leukemia (GRAALL)...
Genomic characterization of pediatric acute lymphoblastic leukemia (ALL) has identified distinct pat...
International audiencePURPOSE: The Group for Research in Adult Acute Lymphoblastic Leukemia (GRAALL)...
Novel target discovery is warranted to improve treatment in adult T-cell acute lymphoblastic leukemi...
Genomic profiling has transformed our understanding of the genetic basis of acute lymphoblastic leuk...
Acute Lymphoblastic Leukemia (ALL) is the most common cancer in children, with close to 200 cases pe...
To characterize the mutational patterns of acute lymphoblastic leukemia (ALL) we performed deep next...
In B-cell precursor acute lymphoblastic leukaemia (B-ALL), the identification of additional genetic ...
To shed light into the molecular bases of B-lineage acute lymphoblastic leukemia lacking known fusio...
To shed light into the molecular bases of B-lineage acute lymphoblastic leukemia lacking known fusio...
Acute lymphoblastic leukemia (ALL) is a hematological malignancy that is characterized by uncontroll...
In contrast to acute lymphoblastic leukemia in children, adult cases of this disease are associated ...
Acute lymphoblastic leukaemia (ALL) is the commonest childhood cancer and an important cause of morb...
B-precursor acute lymphoblastic leukemia (B-ALL) is the most common childhood tumor and the leading ...
International audiencePURPOSE: The Group for Research in Adult Acute Lymphoblastic Leukemia (GRAALL)...
International audiencePURPOSE: The Group for Research in Adult Acute Lymphoblastic Leukemia (GRAALL)...
Genomic characterization of pediatric acute lymphoblastic leukemia (ALL) has identified distinct pat...
International audiencePURPOSE: The Group for Research in Adult Acute Lymphoblastic Leukemia (GRAALL)...
Novel target discovery is warranted to improve treatment in adult T-cell acute lymphoblastic leukemi...
Genomic profiling has transformed our understanding of the genetic basis of acute lymphoblastic leuk...
Acute Lymphoblastic Leukemia (ALL) is the most common cancer in children, with close to 200 cases pe...
To characterize the mutational patterns of acute lymphoblastic leukemia (ALL) we performed deep next...
In B-cell precursor acute lymphoblastic leukaemia (B-ALL), the identification of additional genetic ...
To shed light into the molecular bases of B-lineage acute lymphoblastic leukemia lacking known fusio...
To shed light into the molecular bases of B-lineage acute lymphoblastic leukemia lacking known fusio...
Acute lymphoblastic leukemia (ALL) is a hematological malignancy that is characterized by uncontroll...
In contrast to acute lymphoblastic leukemia in children, adult cases of this disease are associated ...
Acute lymphoblastic leukaemia (ALL) is the commonest childhood cancer and an important cause of morb...
B-precursor acute lymphoblastic leukemia (B-ALL) is the most common childhood tumor and the leading ...
International audiencePURPOSE: The Group for Research in Adult Acute Lymphoblastic Leukemia (GRAALL)...
International audiencePURPOSE: The Group for Research in Adult Acute Lymphoblastic Leukemia (GRAALL)...
Genomic characterization of pediatric acute lymphoblastic leukemia (ALL) has identified distinct pat...
International audiencePURPOSE: The Group for Research in Adult Acute Lymphoblastic Leukemia (GRAALL)...